Clinical Trials Related to Jalyn (Dutasteride / Tamsulosin)

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State [Recruiting]
The purpose of this study is to assess the bioequivalence of the second generation
dutasteride and tamsulosin hydrochloride (HCL) combination capsule versus currently
available commercial combination of dutasteride 0. 5 milligram (mg) and tamsulosin HCL 0. 4 mg
capsule in healthy adult male subjects. Subjects in this study will receive either a single
oral dose of the second generation dutasteride 0. 5 mg and tamsulosin 0. 4 mg combination
capsule or a single dose of commercially available combination of dutasteride 0. 5 mg and
tamsulosin HCL 0. 4 mg followed by a 28-day washout period both in fasted state. The study
will enroll approximately 92 healthy adult male subjects in order to complete approximately
76 evaluable subjects. The total duration of a subject's involvement in this study is
anticipated to be approximately 12 weeks.

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State [Recruiting]
The purpose of this study is to assess the bioequivalence of the second generation
dutasteride and tamsulosin hydrochloride (HCL) combination capsule versus currently
available commercial combination of dutasteride 0. 5 milligrams (mg) and tamsulosin HCL 0. 4
mg capsule in healthy adult male subjects. Subjects in this study will receive either a
single oral dose of the second generation dutasteride 0. 5 mg and tamsulosin 0. 4 mg
combination capsule or a single dose of commercially available combination of dutasteride
0. 5 mg and tamsulosin HCL 0. 4 mg capsule followed by a 28-day washout period both in fed
state. The study will enroll approximately 92 healthy adult male subjects in order to
complete approximately 76 evaluable subjects. The total duration of a subject's involvement
in this study is anticipated to be approximately 12 weeks.